Association between metabolic syndrome, hepatic steatosis, and testosterone deficiency: evidences from studies with men and rodents

References

• Schindler AE. Climacteric symptoms and hormones. Gynecol Endocrinol. 2006;22:151–154.
   PubMed Web of Science ®Google Scholar
• Solstad K, Garde K. Middle-aged Danish men’s ideas of a male climacteric–and of the female climacteric. Maturitas. 1992;15:7–16.
   PubMed Web of Science ®Google Scholar
• Juul A, Skakkebaek NE. Androgens and the aging male. Hum Reprod Update. 2002;8:423–433.
   PubMed Web of Science ®Google Scholar
• Tenover JS. Androgen administration to aging men. Endocrinol Metab Clin North Am. 1994;23:877–892.
   PubMed Web of Science ®Google Scholar
• Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab. 1981;53:58–68.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. Serum bioavailability of sex steroid hormones. Clin Endocrinol Metab. 1986;15:259–278.
   PubMedGoogle Scholar
• Lapauw B, Goemaere S, Zmierczak H, et al. The decline of serum testosterone levels in community-dwelling men over 70 years of age: descriptive data and predictors of longitudinal changes. Eur J Endocrinol. 2008;159:459–468.
   PubMed Web of Science ®Google Scholar
• Wu FC, Tajar A, Pye SR, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab. 2008;93:2737–2745.
   PubMed Web of Science ®Google Scholar
• McBride JA, Carson CC, 3rd, Coward RM. Testosterone deficiency in the aging male. Ther Adv Urol. 2016;8:47–60.
   PubMed Web of Science ®Google Scholar
• Samaras N, Samaras D, Lang PO, et al. A view of geriatrics through hormones. What is the relation between andropause and well-known geriatric syndromes? Maturitas. 2013;74:213–219.
   PubMed Web of Science ®Google Scholar
• Lunenfeld B, Mskhalaya G, Zitzmann M, et al. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male. 2015;18:5–15.
   PubMed Web of Science ®Google Scholar
• Wu FC, Tajar A, Beynon JM, et al.; EMAS Group. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363:123–135.
   PubMed Web of Science ®Google Scholar
• Maneesh M, Dutta S, Chakrabarti A, et al. Alcohol abuse-duration dependent decrease in plasma testosterone and antioxidants in males. Indian J Physiol Pharmacol. 2006;50:291–296.
   PubMedGoogle Scholar
• Shiels MS, Rohrmann S, Menke A, et al. Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men. Cancer Causes Control. 2009;20:877–886.
   PubMed Web of Science ®Google Scholar
• Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, et al. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA. 2008;299:39–52.
   PubMed Web of Science ®Google Scholar
• Li C, Ford ES, Li B, et al. Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men. Diabetes Care. 2010;33:1618–1624.
   PubMed Web of Science ®Google Scholar
• Suzuki R, Allen NE, Appleby PN, et al. Lifestyle factors and serum androgens among 636 middle aged men from seven countries in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control. 2009;20:811–821.
   PubMed Web of Science ®Google Scholar
• Rohrmann S, Shiels MS, Lopez DS, et al. Body fatness and sex steroid hormone concentrations in US men: results from NHANES III. Cancer Causes Control. 2011;22:1141–1151.
   PubMed Web of Science ®Google Scholar
• Fink JE, Hackney AC, Matsumoto M, et al. Mobility and biomechanical functions in the aging male: testosterone and the locomotive syndrome. Aging Male. 2018;29:1–8.
   Web of Science ®Google Scholar
• Harada N. Role of androgens in energy metabolism affecting on body composition, metabolic syndrome, type 2 diabetes, cardiovascular disease, and longevity: lessons from a meta-analysis and rodent studies. Biosci Biotechnol Biochem. 2018;82:1667–1682.
   PubMed Web of Science ®Google Scholar
• Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28:629–636.
   PubMed Web of Science ®Google Scholar
• Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014;2014:943162.
   PubMedGoogle Scholar
• Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20:12.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–1645.
   PubMed Web of Science ®Google Scholar
• Grover S, Malhotra N, Chakrabarti S, et al. Metabolic syndrome in bipolar disorders. Indian J Psychol Med. 2012;34:110–118.
   PubMedGoogle Scholar
• O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16:1–12.
   PubMed Web of Science ®Google Scholar
• Berenji S, Bt Rahmat A, Hanachi P, et al. Metabolic syndrome in Iran. GJHS. 2010;2:6.
   Google Scholar
• Reaven GM. The metabolic syndrome: time to get off the merry-go-round? J Intern Med. 2011;269:127–136.
   PubMed Web of Science ®Google Scholar
• Chen RY, Wittert GA, Andrews GR. Relative androgen deficiency in relation to obesity and metabolic status in older men. Diabetes Obes Metab. 2006;8:429–435.
   PubMed Web of Science ®Google Scholar
• Kupelian V, Page ST, Araujo AB, et al. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab. 2006;91:843–850.
   PubMed Web of Science ®Google Scholar
• Jeong SM, Ham BK, Park MG, et al. Effect of testosterone replacement treatment in testosterone deficiency syndrome patients with metabolic syndrome. Korean J Urol. 2011;52:566–571.
   PubMedGoogle Scholar
• Blaya R, Thomaz LD, Guilhermano F, et al. Total testosterone levels are correlated to metabolic syndrome components. Aging Male. 2016;19:85–89.
   PubMed Web of Science ®Google Scholar
• Angelova P, Kamenov Z, Tsakova A, et al. Interleukin-18 and testosterone levels in men with metabolic syndrome. Aging Male. 2018;21:130–137.
   PubMed Web of Science ®Google Scholar
• Souteiro P, Belo S, Oliveira SC, et al.; AMTCO Group. Insulin resistance and sex hormone-binding globulin are independently correlated with low free testosterone levels in obese males. Andrologia. 2018;50:e13035.
   PubMed Web of Science ®Google Scholar
• Groti K, Zuran I, Antonic B, et al. The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes. Aging Male. 2018;21:158–169.
   PubMed Web of Science ®Google Scholar
• Sakr HF, Hussein AM, Eid EA, et al. Possible mechanisms underlying fatty liver in a rat model of male hypogonadism: a protective role for testosterone. Steroids. 2018;135:21–30.
   PubMed Web of Science ®Google Scholar
• Harada N, Hanaoka R, Horiuchi H, et al. Castration influences intestinal microflora and induces abdominal obesity in high-fat diet-fed mice. Sci Rep. 2016;6:23001.
   PubMed Web of Science ®Google Scholar
• Dubois V, Laurent MR, Jardi F, et al. Androgen deficiency exacerbates high-fat diet-induced metabolic alterations in male mice. Endocrinology. 2016;157:648–665.
   PubMed Web of Science ®Google Scholar
• Xia F, Xu X, Zhai H, et al. Castration-induced testosterone deficiency increases fasting glucose associated with hepatic and extra-hepatic insulin resistance in adult male rats. Reprod Biol Endocrinol. 2013;11:106.
   PubMed Web of Science ®Google Scholar
• Jia Y, Yee JK, Wang C, et al. Testosterone protects high-fat/low-carbohydrate diet-induced nonalcoholic fatty liver disease in castrated male rats mainly via modulating endoplasmic reticulum stress. Am J Physiol Endocrinol Metab. 2018;314:E366–E376.
   PubMed Web of Science ®Google Scholar
• Borbelyova V, Domonkos E, Babickova J, et al. Does long-term androgen deficiency lead to metabolic syndrome in middle-aged rats? Exp Gerontol. 2017;98:38–46.
   PubMed Web of Science ®Google Scholar
• Michael A, Mederos AMB, Scovell JM, Ramasamy R. Can serum testosterone be used as a marker of overall health? Rev Urol. 2015;17:4.
   Google Scholar
• Vermeulen A, Kaufman JM, Deslypere JP, et al. Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men. J Clin Endocrinol Metab. 1993;76:1140–1146.
   PubMed Web of Science ®Google Scholar
• Dwyer AA, Quinton R. The metabolic syndrome in central hypogonadotrophic hypogonadism. Front Horm Res. 2018;49:156–169.
   PubMed Web of Science ®Google Scholar
• Allen NE, Appleby PN, Davey GK, et al. Lifestyle and nutritional determinants of bioavailable androgens and related hormones in British men. Cancer Causes Control. 2002;13:353–363.
   PubMed Web of Science ®Google Scholar
• Moore JB. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. Proc Nutr Soc. 2010;69:211–220.
   PubMed Web of Science ®Google Scholar
• Day CP, James OFW. JO. Steatohepatitis: a tale of two “hits”? Gastroenterology. 1998;114:842–845.
   PubMed Web of Science ®Google Scholar
• Tang YJ, Lee WJ, Chen YT, et al. Serum testosterone level and related metabolic factors in men over 70 years old. J Endocrinol Invest. 2007;30:451–458.
   PubMed Web of Science ®Google Scholar
• Zou Y, Li J, Lu C, et al. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sci. 2006;79:1100–1107.
   PubMed Web of Science ®Google Scholar
• Grosman H, Rosales M, Fabre B, et al. Association between testosterone levels and the metabolic syndrome in adult men. Aging Male. 2014;17:161–165.
   PubMed Web of Science ®Google Scholar
• Haring R, Volzke H, Felix SB, et al. Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania. Diabetes. 2009;58:2027–2031.
   PubMed Web of Science ®Google Scholar
• Rotter I, Ryl A, Grzesiak K, et al. Cross-sectional inverse associations of obesity and fat accumulation indicators with testosterone in non-diabetic aging men. Int J Environ Res Public Health. 2018;15:1207.
   Web of Science ®Google Scholar
• Ugwu TE, Ikem RT, Kolawole BA, et al. Clinicopathologic assessment of hypogonadism in men with type 2 diabetes mellitus. Indian J Endocr Metab. 2016;20:667–673.
   PubMedGoogle Scholar
• Tan WS, Ng CJ, Khoo EM, et al. The triad of erectile dysfunction, testosterone deficiency syndrome and metabolic syndrome: findings from a multi-ethnic Asian men study (The Subang Men’s Health Study). Aging Male. 2011;14:231–236.
   PubMed Web of Science ®Google Scholar
• Fillo J, Breza J, Levcikova M, et al. Occurrence of erectile dysfunction, testosterone deficiency syndrome and metabolic syndrome in patients with abdominal obesity. Where is a sufficient level of testosterone? Int Urol Nephrol. 2012;44:1113–1120.
   PubMed Web of Science ®Google Scholar
• Garcia-Cruz E, Leibar-Tamayo A, Romero-Otero J, et al. Marked testosterone deficiency-related symptoms may be associated to higher metabolic risk in men with low testosterone levels. J Sex Med. 2014;11:2292–2301.
   PubMed Web of Science ®Google Scholar
• Kwon H, Lee DG, Kang HC, et al. The relationship between testosterone, metabolic syndrome, and mean carotid intima-media thickness in aging men. Aging Male. 2014;17:211–215.
   PubMed Web of Science ®Google Scholar
• Maiorino MI, Bellastella G, Giugliano D, et al. From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome. J Endocrinol Invest. 2018;41:1249–1258.
   PubMed Web of Science ®Google Scholar
• Kawada T, Otsuka T, Endo T, et al. Aging, components of metabolic syndrome and serum C-reactive protein showed significant relationship with carotid atherosclerosis. Aging Male. 2012;15:42–47.
   PubMed Web of Science ®Google Scholar
• Mohamad NV, Wong SK, Wan Hasan WN, et al. The relationship between circulating testosterone and inflammatory cytokines in men. Aging Male. 2019;22:129–140.
   PubMed Web of Science ®Google Scholar
• Maggio M, Blackford A, Taub D, et al. Circulating inflammatory cytokine expression in men with prostate cancer undergoing androgen deprivation therapy. J Androl. 2006;27:725–728.
   PubMedGoogle Scholar
• Zhao J, Jiang C, Lam TH, et al. Genetically predicted testosterone and systemic inflammation in men: a separate-sample Mendelian randomization analysis in older Chinese men. PLoS One. 2015;10:e0126442.
   PubMed Web of Science ®Google Scholar
• Huang G, Travison T, Maggio M, et al. Effects of testosterone replacement on metabolic and inflammatory markers in men with opioid-induced androgen deficiency. Clin Endocrinol. 2016;85:232–238.
   PubMed Web of Science ®Google Scholar
• Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84:3666–3672.
   PubMed Web of Science ®Google Scholar
• Erenpreiss J, Fodina V, Pozarska R, et al. Prevalence of testosterone deficiency among aging men with and without morbidities. Aging Male. 2019.
   PubMed Web of Science ®Google Scholar
• Nanjee MN, Wheeler MJ. Plasma free testosterone–is an index sufficient? Ann Clin Biochem. 1985;22:387–390.
   PubMed Web of Science ®Google Scholar
• Jiann BP, Hsieh JT, Liu SP, et al. Associations of endogenous testosterone and lipid profiles in middle-aged to older Taiwanese men. Int J Impot Res. 2011;23:62–69.
   PubMed Web of Science ®Google Scholar
• Tajar A, Huhtaniemi IT, O'Neill TW, et al.; EMAS Group. Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). J Clin Endocrinol Metab. 2012;97:1508–1516.
   PubMed Web of Science ®Google Scholar
• Ho CH, Jaw FS, Wu CC, et al. The prevalence and the risk factors of testosterone deficiency in newly diagnosed and previously known type 2 diabetic men. J Sex Med. 2015;12:389–397.
   PubMed Web of Science ®Google Scholar
• Agarwal PK, Singh P, Chowdhury S, et al. A study to evaluate the prevalence of hypogonadism in Indian males with Type-2 diabetes mellitus. Indian J Endocrinol Metab. 2017;21:64–70.
   PubMedGoogle Scholar
• Golan R, Scovell JM, Ramasamy R. Age-related testosterone decline is due to waning of both testicular and hypothalamic-pituitary function. Aging Male. 2015;18:201–204.
   PubMed Web of Science ®Google Scholar
• Plymate SR, Matej LA, Jones RE, et al. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab. 1988;67:460–464.
   PubMed Web of Science ®Google Scholar
• Simo R, Saez-Lopez C, Barbosa-Desongles A, et al. Novel insights in SHBG regulation and clinical implications. Trends Endocrinol Metab. 2015;26:376–383.
   PubMed Web of Science ®Google Scholar
• Goncharov NP, Katsya GV, Chagina NA, et al. Three definitions of metabolic syndrome applied to a sample of young obese men and their relation with plasma testosterone. Aging Male. 2008;11:118–122.
   PubMed Web of Science ®Google Scholar
• Katabami T, Kato H, Asahina T, et al. Serum free testosterone and metabolic syndrome in Japanese men. Endocr J. 2010;57:533–539.
   PubMed Web of Science ®Google Scholar
• Barbonetti A, Vassallo MRC, Cotugno M, et al. Low testosterone and non-alcoholic fatty liver disease: evidence for their independent association in men with chronic spinal cord injury. J Spinal Cord Med. 2016;39:7.
   Web of Science ®Google Scholar
• Hasanain AFA, Mahdy RE, Mahran AMA, et al. Erectile dysfunction in patients with nonalcoholic fatty liver disease. Arab J Gastroenterol. 2017;18:21–24.
   PubMed Web of Science ®Google Scholar
• Seo NK, Koo HS, Haam JH, et al. Prediction of prevalent but not incident non-alcoholic fatty liver disease by levels of serum testosterone. J Gastroenterol Hepatol. 2015;30:1211–1216.
   PubMed Web of Science ®Google Scholar
• Kim D, Touros A, Kim WR. Nonalcoholic fatty liver disease and metabolic syndrome. Clin Liver Dis. 2018;22:133–140.
   PubMed Web of Science ®Google Scholar
• Yang Q, Wu K, Zhuang Y, et al. Association of total testosterone, free testosterone, bioavailable testosterone and sex hormone-binding globulin with hepatic steatosis and the ratio of aspartate aminotransferase to alanine aminotransferase. Endocr J. 2018;65:915–921.
   PubMed Web of Science ®Google Scholar
• Hoyos CM, Yee BJ, Phillips CL, et al. Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial. Eur J Endocrinol. 2012;167:531–541.
   PubMed Web of Science ®Google Scholar
• Albhaisi S. Non-invasive imaging modalities in nonalcoholic fatty liver disease: where do we stand? Eur Med J Hepatol. 2019;7:80–85.
   Google Scholar
• Saad F, Gooren L, Haider A, et al. An exploratory study of the effects of 12 months administration of the novel long-acting testosterone undecanoate on measures of sexual function and the metabolic syndrome. Arch Androl. 2007;53:5.
   PubMedGoogle Scholar
• Singh SK, Goyal R, Pratyush DD. Is hypoandrogenemia a component of metabolic syndrome in males? Exp Clin Endocrinol Diabetes. 2010;119:30–35.
   PubMed Web of Science ®Google Scholar
• Traish AM, Haider A, Doros G, et al. Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study. Int J Clin Pract. 2014;68:314–329.
   PubMed Web of Science ®Google Scholar
• Traish AM, Haider A, Haider KS, et al. Long-term testosterone therapy improves cardiometabolic function and reduces risk of cardiovascular disease in men with hypogonadism: a real-life observational registry study setting comparing treated and untreated (control) groups. J Cardiovasc Pharmacol Ther. 2017;22:414–433.
   PubMed Web of Science ®Google Scholar
• Haider KS, Haider A, Doros G, et al. Long-term testosterone therapy improves urinary and sexual function, and quality of life in men with hypogonadism: results from a propensity matched subgroup of a controlled registry study. J Urol. 2018;199:257–265.
   PubMed Web of Science ®Google Scholar
• Yassin A, Nettleship JE, Talib RA, et al. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters. Aging Male. 2016;19:64–69.
   PubMed Web of Science ®Google Scholar
• Dias JP, Shardell MD, Carlson OD, et al. Testosterone vs. aromatase inhibitor in older men with low testosterone: effects on cardiometabolic parameters. Andrology. 2017;5:31–40.
   PubMed Web of Science ®Google Scholar
• Canguven O, Talib RA, El Ansari W, et al. Vitamin D treatment improves levels of sexual hormones, metabolic parameters and erectile function in middle-aged vitamin D deficient men. Aging Male. 2017;20:9–16.
   PubMed Web of Science ®Google Scholar
• Xu Y, Shao X, Yao Y, et al. Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated meta-analysis. J Cancer Res Clin Oncol. 2014;140:1465–1477.
   PubMed Web of Science ®Google Scholar
• Abdollah F, Briganti A, Suardi N, et al. Metabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and prevention. Korean J Urol. 2011;52:507–516.
   PubMedGoogle Scholar
• Zhang X, Zeng X, Liu Y, et al. Impact of metabolic syndrome on benign prostatic hyperplasia in elderly Chinese men. Urol Int. 2014;93:214–219.
   PubMed Web of Science ®Google Scholar
• Park YW, Kim SB, Kwon H, et al. The relationship between lower urinary tract symptoms/benign prostatic hyperplasia and the number of components of metabolic syndrome. Urology. 2013;82:674–679.
   PubMed Web of Science ®Google Scholar
• Cakir SS, Ozcan L, Polat EC, et al. Statins are effective in the treatment of benign prostatic hyperplasia with metabolic syndrome. Aging Male. 2018.
   Web of Science ®Google Scholar
• Caliskan S, Kaba S, Ozsoy E, et al. The effect of metabolic syndrome on prostate cancer final pathology. J Cancer Res Ther. 2019;15:S47–S50.
   PubMed Web of Science ®Google Scholar
• Goh VH, Hart WG. The association of metabolic syndrome and aging with cognition in Asian men. Aging Male. 2014;17:216–222.
   PubMed Web of Science ®Google Scholar
• Magee DE, Singal RK. Androgen deprivation therapy: indications, methods of utilization, side effects and their management. Can J Urol. 2020;27:11–16.
   PubMedGoogle Scholar
• Ostergren PB, Kistorp C, Fode M, et al. Metabolic consequences of gonadotropin-releasing hormone agonists vs orchiectomy: a randomized clinical study. BJU Int. 2019;123:602–611.
   PubMed Web of Science ®Google Scholar
• Mangiola S, Stuchbery R, McCoy P, et al. Androgen deprivation therapy promotes an obesity-like microenvironment in periprostatic fat. Endocr Connect. 2019;8:547–558.
   PubMed Web of Science ®Google Scholar
• Christoffersen B, Raun K, Svendsen O, et al. Evalution of the castrated male Sprague-Dawley rat as a model of the metabolic syndrome and type 2 diabetes. Int J Obes (Lond). 2006;30:1288–1297.
   PubMed Web of Science ®Google Scholar
• Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. QJM. 2010;103:71–83.
   PubMed Web of Science ®Google Scholar
• Kelly DM, Nettleship JE, Akhtar S, et al. Testosterone suppresses the expression of regulatory enzymes of fatty acid synthesis and protects against hepatic steatosis in cholesterol-fed androgen deficient mice. Life Sci. 2014;109:95–103.
   PubMed Web of Science ®Google Scholar
• Nikolaenko L, Jia Y, Wang C, et al. Testosterone replacement ameliorates nonalcoholic fatty liver disease in castrated male rats. Endocrinology. 2014;155:417–428.
   PubMed Web of Science ®Google Scholar